Acetaminophen improves protein translational signaling in aged skeletal muscle

Rejuvenation Research

Volumn 13, Issue 5, 2010, Pages 571-579

  Wu, Miaozong ^a   Liu, Hua ^a,b   Fannin, Jacqueline ^a   Katta, Anjaiah ^a   Wang, Yeling ^a,c   Arvapalli, Ravi Kumar ^a   Paturi, Satyanarayana ^a   Karkala, Sunil K ^a   Rice, Kevin M ^a   Blough, Eric R ^a  

^a MARSHALL UNIVERSITY   (United States)

^b SOUTHEAST UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROGEN PEROXIDE; INITIATION FACTOR 2ALPHA; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PARACETAMOL; PROTEIN KINASE B; S6 KINASE; THREONINE; TUBERIN;

AGING; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; MALE; MUSCLE ATROPHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SOLEUS MUSCLE; TRANSLATION REGULATION;

ACETAMINOPHEN; AGING; ANIMALS; CARRIER PROTEINS; EUKARYOTIC INITIATION FACTOR-2; EUKARYOTIC INITIATION FACTOR-4E; MALE; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; RATS; RIBOSOMAL PROTEIN S6; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; EUKARYOTA; MAMMALIA; RAPTORES; RATTUS;

EID: 78049300566     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2009.1015     Document Type: Article

References (40)

1. Brooks SV, Faulkner JA. Skeletal muscle weakness in old age: Underlying mechanisms. Med Sci Sports Exerc 1994;26:432-439.
2. Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, Morton DJ, Wingard DL, Barrett-Connor E. Sarcopenia in elderly men and women: The Rancho Bernardo study. Am J Prev Med 2003;25:226-231.
3. Wu M, Fannin J, Rice KM, Wang B, Blough ER. Effect of aging on cellular mechanotransduction. Ageing Res Rev 2009; doi:10.1016/j.arr.2009.11.002.
4. Nair KS. Muscle protein turnover: methodological issues and the effect of aging. J Gerontol A Biol Sci Med Sci 1995;50(Spec No):107-112.
5. Proctor DN, Balagopal P, Nair KS. Age-related sarcopenia in humans is associated with reduced synthetic rates of specific muscle proteins. J Nutr 1998;128(2 Suppl):351S-355S.
6. Cuthbertson D, Smith K, Babraj J, Leese G, Waddell T, Atherton P, Wackerhage H, Taylor PM, Rennie MJ. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J 2005;19:422-424.
7. Wu M, Desai DH, Kakarla SK, Katta A, Paturi S, Gutta AK, Rice KM, Walker EM Jr, Blough ER. Acetaminophen prevents aging-associated hyperglycemia in aged rats: Effect of aging-associated hyperactivation of p38-MAPK and ERK1/2. Diabetes Metab Res Rev 28 2009;25:279-286.
8. Fukagawa NK, Li M, Liang P, Russell JC, Sobel BE, Absher PM. Aging and high concentrations of glucose potentiate injury to mitochondrial DNA. Free Radic Biol Med 1999;27:1437-1443.
9. Gianni P, Jan KJ, Douglas MJ, Stuart PM, Tarnopolsky MA. Oxidative stress and the mitochondrial theory of aging in human skeletal muscle. Exp Gerontol 2004;39:1391-1400.
10. Wu M, Katta A, Gadde MK, Liu H, Kakarla SK, Fannin J, Paturi S, Arvapalli RK, Rice KM, Wang Y, Blough ER. Aging-associated dysfunction of akt/protein kinase B: S-nitrosylation and acetaminophen intervention. PLoS One 2009;4:e6430.
11. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001;3:1014-1019.
12. Gingras AC, Raught B, Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev 2001;15:807-826.
13. Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phos-phoinositide 3-kinase/akt pathway. Mol Cell 2002;10:151-162.
14. Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphory-lated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002;4:648-657.
15. Beugnet A, Wang X, Proud CG. Target of rapamycin (TOR)-signaling and RAIP motifs play distinct roles in the mammalian TOR-dependent phosphorylation of initiation factor 4E-binding protein 1. J Biol Chem 2003;278:40717-40722.
16. Nojima H, Tokunaga C, Eguchi S, Oshiro N, Hidayat S, Yoshino K, Hara K, Tanaka N, Avruch J, Yonezawa K. The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J Biol Chem 2003;278:15461-15464.
17. Kim DH, Sarbassov DD, Ali SM, Latek RR, Guntur KV, Erdjument-Bromage H, Tempst P, Sabatini DM. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell 2003;11:895-904.
18. Jefferies HB, Reinhard C, Kozma SC, Thomas G. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc Natl Acad Sci USA 1994;91:4441-4445.
19. Ferrari S, Thomas G. S6 phosphorylation and the p70s6k/p85s6k. Crit Rev Biochem Mol Biol 1994;29:385-413.
20. Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R, Sonenberg N. Regulation of 4E-BP1 phosphorylation: A novel two-step mechanism. Genes Dev 1999;13:1422-1437.
21. Brunn GJ, Hudson CC, Sekulic A, Williams JM, Hosoi H, Houghton PJ, Lawrence JC Jr, Abraham RT. Phosphoryla-tion of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 1997;277:99-101.
22. Gingras AC, Kennedy SG, O'Leary MA, Sonenberg N, Hay N. 4E-BP1, a repressor of mRNA translation, is phosphory-lated and inactivated by the Akt(PKB) signaling pathway. Genes Dev 1998;12:502-513.
23. 0-terminal cap in mRNA. Proc Natl Acad Sci USA 1978;75:4843-4847.
24. Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 1999;68:913-963.
25. De Haro C, Mendez R, Santoyo J. The eIF-2alpha kinases and the control of protein synthesis. FASEB J 1996;10:1378-1387.
26. Kimball SR. Eukaryotic initiation factor eIF2. Int J Biochem Cell Biol 1999;31:25-29.
27. Greenhaff PL, Karagounis LG, Peirce N, Simpson EJ, Hazell M, Layfield R, Wackerhage H, Smith K, Atherton P, Selby A, Rennie MJ. Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle. Am J Physiol Endocrinol Metab 2008;295:E595-E604.
28. Wilkinson SB, Phillips SM, Atherton PJ, Patel R, Yarasheski KE, Tarnopolsky MA, Rennie MJ. Differential effects of resistance and endurance exercise in the fed state on signalling molecule phosphorylation and protein synthesis in human muscle. J Physiol. 2008;586(Pt 15):3701-3717.
29. Adachi M, Liu Y, Fujii K, Calderwood SK, Nakai A, Imai K, Shinomura Y. Oxidative stress impairs the heat stress response and delays unfolded protein recovery. PLoS One 2009;4:e7719.
30. Back SH, Scheuner D, Han J, Song B, Ribick M, Wang J, Gildersleeve RD, Pennathur S, Kaufman RJ. Translation attenuation through eIF2alpha phosphorylation prevents oxi-dative stress and maintains the differentiated state in beta cells. Cell Metab 2009;10:13-26.
31. Russell ST, Rajani S, Dhadda RS, Tisdale MJ. Mechanism of induction of muscle protein loss by hyperglycaemia. Exp Cell Res 2009;315:16-25.
32. Ji LL. Antioxidant signaling in skeletal muscle: A brief review. Exp Gerontol 2007;42:582-593.
33. Meng Q, Velalar CN, Ruan R. Regulating the age-related oxidative damage, mitochondrial integrity, and anti-oxidative enzyme activity in Fischer 344 rats by supplementation of the antioxidant epigallocatechin-3-gallate. Rejuvenation Res 2008;11:649-660.
34. Paschen W, Hayashi T, Saito A, Chan PH. GADD34 protein levels increase after transient ischemia in the cortex but not in the CA1 subfield: Implications for post-ischemic recovery of protein synthesis in ischemia-resistant cells. J Neurochem 2004;90:694-701.
35. Garrido A, Arancibia C, Campos R, Valenzuela A. Acetaminophen does not induce oxidative stress in isolated rat hepatocytes: Its probable antioxidant effect is potentiated by the flavonoid silybin. Pharmacol Toxicol 1991;69:9-12.
36. Merrill GF, Goldberg E. Antioxidant properties of acetaminophen and cardioprotection. Basic Res Cardiol 2001, 96, 423-430.
37. Tripathy D, Grammas P. Acetaminophen protects brain en-dothelial cells against oxidative stress. Microvasc Res 2009;77:289-296.
38. 2-induced injury in vivo. Exp Biol Med (Maywood) 2008;233:1315-1322.
39. Maharaj H, Maharaj DS, Daya S. Acetylsalicylic acid and acetaminophen protect against oxidative neurotoxicity. Me-tab Brain Dis 2006;21:189-199.
40. Walker EM, Jr., Morrison RG, Dornon L, Laurino JP, Walker SM, Studeny M, Wehner PS, Rice KM, Wu M, Blough ER. Acetaminophen combinations protect against iron-induced cardiac damage in gerbils. Ann Clin Lab Sci 2009;39:378-385.